ISRCTN51184253已完成不适用
Screening-homes to prevent malaria
Medical Research Council Laboratories (The Gambia)0 个研究点目标入组 500 人开始时间: 2006年8月31日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Homes in Farafenni town and surrounding peri-urban villages in which at least one child sleeps.
排除标准
- •Houses that are:
- •1. More than a single storey
- •2. More than four rooms or that have a ceiling, screening or closed eaves
研究者
相似试验
尚未招募
2 期
Severe Malaria A Research and Trials consortium - Multisite Adaptive Platform trialMalariaPACTR202312551082722Imperial College450
进行中（未招募）
不适用
A single centre, randomised, partially-blind, placebo-controlled 3 way crossover pilot study investigating efficacy in terms of heartburn relief after taking (2x250mg) Gaviscon® chewable tablets, (1x20mg) Losec® MUPS® tablet and (2x) Placebo tablets in subjects with heartburn following a refluxogenic meal. - Three-period crossover pilot study in healthy subjects susceptible to heartburn.Investigating efficacy in terms of heatburn relief in healthy subjects following a refluxogenic meal.EUCTR2010-019414-24-GBReckitt Benckiser Healthcare (UK) Ltd
已完成
不适用
Multicentre prospective randomised clinical trial to compare the safety and efficacy of outpatient treatment with oral amoxicillin with that of injectable ampicillin in children aged 3 to 59 months: APPIS II Randomised Controlled Trial (RCT), PakistaPneumoniaISRCTN95821329The Department of Child and Adolescent Health (CAH)/World Health Organization (WHO) (Switzerland)2,100
招募中
不适用
Prospective, randomized controlled, single center study evaluating additional respiration therapy with a PEP trainer to prevent pneumonia in patients with higher neutropenic risk under chemotherapeutic treatment of an acute myeloic leukemiaC92J18Myeloid leukaemiaPneumonia, organism unspecifiedDRKS00019842Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin100
终止
不适用
Renal protection during open heart surgeryacute kidney injuryACTRN12619000128190Monash Health20